• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性唾液腺肿瘤的管理

Management of malignant salivary gland tumors.

作者信息

Byun Y S, Fayos J V, Kim Y H

出版信息

Laryngoscope. 1980 Jun;90(6 Pt 1):1052-60. doi: 10.1002/lary.1980.90.6.1052.

DOI:10.1002/lary.1980.90.6.1052
PMID:7382701
Abstract

A total of 54 patients with major salivary gland tumor were treated with radiation therapy at the University of Michigan from 1955 to 1975, inclusive. Fifteen had total resection and radiation, 16 had subtotal resection and radiation, and 23 were inoperable and received radiation only. Local control rate was different between these groups, 86.7%, 75%, 21.7% respectively, as was survival rate at 5 years, 78.4%, 59.8%, 29.9%. In patients with facial nerve palsy, with combined surgery and radiation, 65.3% local control and 49.7% 5-year survival was obtained. Regional neck node metastasis was noted in 25.5% and distant metastasis in 24.1%. Local tumor control was found to be a very important factor in survival: 70.2% survival in patients with local control and 28.7% without. The authors conclude that a combined radical surgery and postoperative radiation would improve the prognosis of these patients with major salivary gland tumors.

摘要

1955年至1975年(含)期间,密歇根大学共有54例大唾液腺肿瘤患者接受了放射治疗。其中15例接受了全切除及放疗,16例接受了次全切除及放疗,23例无法手术,仅接受了放疗。这些组之间的局部控制率不同,分别为86.7%、75%、21.7%,5年生存率也不同,分别为78.4%、59.8%、29.9%。对于面神经麻痹患者,联合手术及放疗后,局部控制率为65.3%,5年生存率为49.7%。区域颈部淋巴结转移率为25.5%,远处转移率为24.1%。发现局部肿瘤控制是生存的一个非常重要的因素:局部控制的患者生存率为70.2%,未控制的患者生存率为28.7%。作者得出结论,根治性手术联合术后放疗将改善这些大唾液腺肿瘤患者的预后。

相似文献

1
Management of malignant salivary gland tumors.恶性唾液腺肿瘤的管理
Laryngoscope. 1980 Jun;90(6 Pt 1):1052-60. doi: 10.1002/lary.1980.90.6.1052.
2
Salivary gland malignant neoplasms: treatment and prognosis.涎腺恶性肿瘤:治疗与预后
Int J Radiat Oncol Biol Phys. 1986 May;12(5):747-54. doi: 10.1016/0360-3016(86)90032-5.
3
Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure.小唾液腺恶性肿瘤的术后放射治疗。结果及失败模式。
Cancer. 1994 May 15;73(10):2563-9. doi: 10.1002/1097-0142(19940515)73:10<2563::aid-cncr2820731018>3.0.co;2-x.
4
Management and outcome of patients with malignant salivary gland tumors.恶性唾液腺肿瘤患者的管理与预后
J Oral Maxillofac Surg. 2005 Jul;63(7):917-28. doi: 10.1016/j.joms.2005.03.006.
5
Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy.低度恶性涎腺癌:治疗结果、手术范围及术后辅助放疗指征
Ann Surg Oncol. 2016 Dec;23(13):4368-4375. doi: 10.1245/s10434-016-5353-6. Epub 2016 Jun 24.
6
Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.唾液腺癌:局部区域控制、远处转移及总生存的独立预后因素:荷兰头颈肿瘤协作组的结果
Head Neck. 2004 Aug;26(8):681-92; discussion 692-3. doi: 10.1002/hed.10400.
7
[Clinical analysis of sixteen cases of lymphoepithelial carcinoma of salivary gland].涎腺淋巴上皮癌16例临床分析
Ai Zheng. 2005 Nov;24(11):1384-7.
8
[Radiotherapy of salivary gland carcinomas (results from 80 patients)].[唾液腺癌的放射治疗(80例患者的结果)]
Strahlentherapie. 1976 Nov;152(5):395-403.
9
Major salivary gland tumors: treatment results and prognostic factors.大唾液腺肿瘤:治疗结果与预后因素
Laryngoscope. 1986 Oct;96(10):1139-44. doi: 10.1288/00005537-198610000-00014.
10
Radiation therapy for patients of malignant salivary gland tumors with positive surgical margins.手术切缘阳性的恶性涎腺肿瘤患者的放射治疗
Strahlenther Onkol. 1994 Jun;170(6):342-6.

引用本文的文献

1
Primary Intracranial Manifestation of a Carcinosarcoma.癌肉瘤的原发性颅内表现
Asian J Neurosurg. 2018 Jul-Sep;13(3):923-927. doi: 10.4103/ajns.AJNS_19_18.
2
Carcinoma of the major salivary glands.大唾液腺癌
Ann R Coll Surg Engl. 1992 May;74(3):186-91.